Lasek R, Müller-Oerlinghausen B
Arzneimittelkommission der deutschen Arzteschaft, Köln.
Z Arztl Fortbild Qualitatssich. 1997 Jul;91(4):375-83.
The growing flood of information on drug therapy, which is increasingly overwhelming the individual physician, and the simultaneous demand for high-quality, individual therapy, call for guidelines recommending appropriate therapeutic measures for a given indication. The Drug Commission of the German Medical Profession, a scientific committee of the German Medical Association, has set itself the task of providing assistance in this context by elaborating scientifically-based, practice-oriented therapeutic guidelines. These guidelines were drawn up in accordance with a defined procedure and represent the consensus reached between the appropriate independent experts, the general practitioners and the members of the executive committee of the Drug Commission. This review presents the background, aims, procedures and criteria for assessment involved in the elaboration of the guidelines and attempts to define the position of the therapeutic guidelines in comparison to similar activities of other institutions in Germany.
关于药物治疗的信息如潮水般不断增加,这使得个体医生应接不暇,同时对高质量的个体化治疗也有需求,因此需要有针对特定适应症推荐适当治疗措施的指南。德国医学专业药物委员会是德国医学协会的一个科学委员会,其给自己设定的任务是,通过制定基于科学、面向实践的治疗指南,在此背景下提供帮助。这些指南是按照既定程序制定的,代表了相关独立专家、全科医生以及药物委员会执行委员会成员之间达成的共识。本综述介绍了制定指南所涉及的背景、目的、程序和评估标准,并试图界定治疗指南相对于德国其他机构类似活动的地位。